Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06652542 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial
NCT06652542 · ClinicalTrials.gov record · last posted 2026-08-17

Asthma Exacerbations & Respiratory Management International Survey

Study acronym: AERMIS
StatusCompleted
PhaseNot specified
Started2024-02-20
View on ClinicalTrials.gov ↗
from the ClinicalTrials.gov record
Asthma is a chronic health condition that affects 300 million humans worldwide and is thought to cause around 1.000 deaths per day. It's estimated that asthma leads to a significant increase in disability adjusted life years (DALYs). Acute asthma exacerbations affect 25-56% of patients with asthma and represent 8% of intensive care unit (ICU) admissions. Acute asthma exacerbations continue to burden different health systems, particularly emergency units and intensive care units, despite vast advances in pharmacological treatment of asthma, development of evidence-based clinical practice guidelines to improve care of asthma. This alarming situation indicates non-consensus regarding the best approach for managing acute exacerbations of asthma. Despite that variations in clinical practice regarding diagnosis, prevention, education, long-term management and symptom control of asthma have been thoroughly studied globally, less light has been shed on divergence of physicians' approaches when encountering asthmatic patients during acute exacerbations.

Protocol amendment history 3 changes detected by DataLookout

2026-08-18
notable
Trial status changed: Enrolling by Invitation → Completed
2026-08-18
critical
Enrollment reduced: 300 → 93 participants
2026-08-18
minor
Completion moved earlier: 2025-12-20 → 2025-02-20
Trial Details
NCT Number NCT06652542
Lead Sponsor Assiut University
Collaborators: International Association of Noninvasive Mechanical Ventilation
Conditions Acute Asthma Exacerbations
Enrollment 93 participants
Start Date 2024-02-20
Primary Completion 2025-02-20 (estimated)
Study Completion 2025-02-20 (estimated)
Updated on ClinicalTrials.gov 2026-08-17